Journal article icon

Journal article

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.

Abstract:

BACKGROUND: In the UK, chemotherapy is the standard treatment for inoperable, locally advanced, non-metastatic pancreatic cancer. Chemoradiotherapy is also an acceptable treatment option, for which gemcitabine, fluorouracil, or capecitabine can be used as concurrent chemotherapy agents. We aimed to assess the activity, safety, and feasibility of both gemcitabine-based and capecitabine-based chemoradiotherapy after induction chemotherapy for patients with locally advanced pancreatic cancer. ME...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Role:
Author
Expand authors...
Journal:
Lancet. Oncology
Volume:
14
Issue:
4
Pages:
317-326
Publication date:
2013-04-01
DOI:
EISSN:
1474-5488
ISSN:
1470-2045
Source identifiers:
387815
Language:
English
Keywords:
Pubs id:
pubs:387815
UUID:
uuid:abb28309-47f7-4de0-ad0b-cee6cdb7396a
Local pid:
pubs:387815
Deposit date:
2013-11-16

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP